转诊至大型学术中心妇科肿瘤科的患者行单孔腹腔镜附件肿块切除术后的结局
回顾性分析2009至2015年转诊至妇科肿瘤科后行单孔腹腔镜附件肿块手术的322例患者共325次手术,中位随访42.7个月;87.4%为良性,30天不良结局少,切口疝发生率4.0%,糖尿病和肥胖是疝的显著预测因素。
要点
- 单孔腹腔镜附件肿块手术中87.4%为良性病变,7.4%恶性,5.2%交界性。
- 30天再手术率0.0%,术中损伤1.5%,静脉血栓栓塞0.3%,输血0.6%。
- 切口疝发生率4.0%,糖尿病(p = .03)和肥胖(p = .04)为显著预测因素。
核心结论
- 在妇科肿瘤科行单孔腹腔镜附件肿块切除术的患者中良性病变比例高,该手术可行且安全,手术结局良好,短期不良结局少见,切口疝发生率低。
研究设计与样本
- 回顾性分析(加拿大工作组分类II.2),单学术机构多医院中心,纳入2009至2015年转诊至妇科肿瘤科后至少接受1次单孔腹腔镜附件肿块手术的女性。
- 共322例患者行325次手术,中位随访42.7个月。
主要发现
- 中位年龄54.5岁,中位体重指数28.1 kg/m2,中位手术时间90.0分钟,中位肿块直径6.4 cm,17.9%(n = 60)大于10 cm。
- 肿块分类为单纯性11.4%、复杂性69.5%;良性87.4%、恶性7.4%、交界性5.2%。
- 良性肿块组织学:生理性16.6%、浆液性囊腺瘤19.1%、黏液性囊腺瘤6.8%、子宫内膜异位囊肿12.3%、肌瘤12.3%、成熟畸胎瘤9.2%;恶性病例中浆液性癌最常见(58.3%)。
- 30天不良结局:再手术0.0%、术中损伤1.5%、静脉血栓栓塞0.3%、输血0.6%;切口蜂窝织炎4.6%。
- 切口疝发生率4.0%,中位发生时间18.3个月;糖尿病(p = .03)和肥胖(p = .04)为疝的显著预测因素,肿块复杂性(p = .28)、美国麻醉医师学会分级(p = .83)和吸烟(p = .82)不是。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To report surgical and pathologic outcomes after single-port laparoscopy (SPL) for adnexal masses in patients referred to a gynecologic oncology practice at a single academic institution. DESIGN: A retrospective analysis (Canadian Task Force Classification II.2). SETTING: A single academic institution with multiple hospital centers. PATIENTS: Women who underwent at least 1 single-port laparoscopic surgery for the treatment of an adnexal mass from 2009 to 2015 after referral to a gynecologic oncology practice. INTERVENTION: Data were collected on the surgical procedure, patient demographic variables, 30-day surgical outcomes, and hernia development. MEASUREMENTS AND MAIN RESULTS: Three hundred twenty-five surgeries were performed in 322 patients with a median follow-up of 42.7 months. The median age was 54.5 years, and the median body mass index was 28.1 kg/m2. All patients underwent unilateral or bilateral salpingectomy or oophorectomy with or without hysterectomy (26.5%). The median operative time was 90.0 minutes. The median mass dimension was 6.4 cm with 17.9% (n = 60) greater than 10 cm. Masses were categorized as simple (11.4%) and complex (69.5%). Although the majority (87.4%) of masses were benign, 7.4% were malignant, and 5.2% were borderline. Benign masses were physiologic (16.6%), serous cystadenomas (19.1%), mucinous cystadenomas (6.8%), endometriomas (12.3%), myomas (12.3%), and mature teratomas (9.2%). In malignant cases (7.4%), serous carcinoma was the most frequent histology (58.3%). The rate of adverse outcomes within 30 days, including reoperation (0.0%), intraoperative injury (1.5%), venous thromboembolism (0.3%), and transfusion (0.6%), was low. The development of incisional cellulitis was 4.6%. The rate of incisional hernia was 4.0%, with a median occurrence of 18.3 months. Diabetes mellitus (p = .03) and obesity (p = .04) were significant predictors for a hernia, but mass complexity (p = .28), American Society of Anesthesiologists class (p = .83), and smoking (p = .82) were not. CONCLUSION: In patients undergoing SPL for the removal of adnexal masses in a gynecologic oncology practice, the rate of benign disease is high. SPL removal of adnexal masses is feasible and safe with favorable surgical outcomes, rare short-term adverse outcomes, and a low incisional hernia rate.
引用
- Moulton LJ, Jernigan AM, Michener CM, et al. Postoperative Outcomes after Single-port Laparoscopic Removal of Adnexal Masses in Patients Referred to Gynecologic Oncology at a Large Academic Center. J Minim Invasive Gynecol. 2017. PMID: 28673874. doi:10.1016/j.jmig.2017.06.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。